Drug Trial Radar · NCT01686152
Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
Last checked: Nov 20, 2026Latest source record: Nov 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
589
Actual
Start
Sep 2012
Primary completion
Aug 2013
Study completion Aug 2013
Sponsor
- Lead sponsor
- Teva Pharmaceuticals USATeva (TEVA)
- Sponsor type
- Industry
- First posted
- Sep 17, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine the comparability of the safety and efficacy of Imiquimod Cream, 3.75% and Zyclara (imiquimod) Cream, 3.75% (the reference listed drug) in subjects with actinic keratosis (AK) of the face or balding scalp. It will also be determined whether the efficacy of each of the two active treatments is superior to that of the Vehicle cream.
Conditions
- Actinic Keratosis
Interventions
Imiquimod Cream, 3.75%Drug
Zyclara®Drug
Vehicle of Test ProductOther
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment Success/Failure at Visit 5/Week 14Time frame: 14 Weeks
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Radiant Research, Inc.
Tucson, Arizona
Encino Research Center
Encino, California
Dermatology Research Associates
Los Angeles, California
Northern California Research
Sacramento, California
Skin Surgery Medical Group, Inc.
San Diego, California
Longmont Clinic, PC
Longmont, Colorado
Visions Clinical Research
Boynton Beach, Florida
Tampa Bay Medical Research
Clearwater, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
International Dermatology Research, Inc.
Miami, Florida
Tory Sullivan, M.D., P.A.
North Miami Beach, Florida
Park Avenue Dermatology, PA
Orange Park, Florida
Leavitt Medical Associates of Florida dba Ameriderm Research
Ormond Beach, Florida
Radiant Research, Inc.
Pinellas Park, Florida
MedaPhase, Inc.
Newnan, Georgia
Altman Dermatology Associates
Arlington Heights, Illinois
The Indiana Clinical Trials Center
Plainfield, Indiana
Dermatology Specialists Research LLC
Louisville, Kentucky
Radiant Research, Inc.
Cincinnati, Ohio
Oregon Medical Research Center, PC
Portland, Oregon
Philadelphia Institute of Dermatology
Fort Washington, Pennsylvania
Omega Medical Research
Warwick, Rhode Island
Research Across America
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.